These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38779889)

  • 1. The Clinical Effectiveness of Fidaxomicin Compared to Vancomycin in the Treatment of Clostridioides difficile Infection, A Single-Center Real-World Experience.
    Alsoubani M; Chow JK; Rodday AM; McDermott LA; Walk ST; Kent DM; Snydman DR
    J Infect Dis; 2024 Dec; 230(6):1501-1509. PubMed ID: 38779889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced Vancomycin Susceptibility in Clostridioides difficile Is Associated With Lower Rates of Initial Cure and Sustained Clinical Response.
    Eubank TA; Dureja C; Garey KW; Hurdle JG; Gonzales-Luna AJ
    Clin Infect Dis; 2024 Jul; 79(1):15-21. PubMed ID: 38382090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiome-preserving antibiotics for the treatment of Clostridioides difficile infection: a systematic review and meta-analysis.
    Kravets AM; Hanneke R; Nelson RL
    Tech Coloproctol; 2023 Dec; 28(1):20. PubMed ID: 38112980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
    Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
    Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment outcomes of mild to moderate Clostridioides difficile infection in inflammatory bowel disease: an Australian experience.
    Jacob R; Chu V; Ng W; Williams AJ; Connor S
    Intern Med J; 2024 Dec; 54(12):2009-2014. PubMed ID: 39422325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.
    Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B
    Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.
    Bryant A; Hiu S; Kunonga PT; Gajjar K; Craig D; Vale L; Winter-Roach BA; Elattar A; Naik R
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015048. PubMed ID: 36161421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fidaxomicin for Clostridium difficile-associated diarrhoea: epidemiological method for estimation of warranted price.
    Sclar DA; Robison LM; Oganov AM; Schmidt JM; Bowen KA; Castillo LV
    Clin Drug Investig; 2012 Aug; 32(8):e17-24. PubMed ID: 22708825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dogs in Rio de Janeiro as reservoirs of Clostridioides difficile ribotypes causing CDI in humans.
    Meireles J; Moraes RFF; Lins D; Oliveira TDS; de Carvalho EB; Rainha K; Ferreira EO
    Anaerobe; 2024 Dec; 90():102917. PubMed ID: 39393610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical and oral steroids for otitis media with effusion (OME) in children.
    Mulvaney CA; Galbraith K; Webster KE; Rana M; Connolly R; Tudor-Green B; Marom T; Daniel M; Venekamp RP; Schilder AG; MacKeith S
    Cochrane Database Syst Rev; 2023 Dec; 12(12):CD015255. PubMed ID: 38088821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.
    Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF
    Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.
    Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L
    Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidants for female subfertility.
    Showell MG; Mackenzie-Proctor R; Jordan V; Hart RJ
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD007807. PubMed ID: 32851663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospitalized patients on proton pump inhibitors for stress ulcer prophylaxis have a higher risk of Clostridioides difficile infection compared with those on histamine-2 receptor antagonists.
    Wu LH; Wang JL; Liu YH; Su CC; Yang YK; Lin SJ; Cheng CL
    J Hosp Infect; 2024 Dec; 154():9-17. PubMed ID: 39369994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.
    Davenport C; Arevalo-Rodriguez I; Mateos-Haro M; Berhane S; Dinnes J; Spijker R; Buitrago-Garcia D; Ciapponi A; Takwoingi Y; Deeks JJ; Emperador D; Leeflang MMG; Van den Bruel A;
    Cochrane Database Syst Rev; 2024 Dec; 12(12):CD014780. PubMed ID: 39679851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent Clostridioides difficile infections in solid organ transplant recipients: The international CALIPSO study.
    Tiseo G; Yahav D; Atamna A; Avni T; Causse M; Pérez-Nadales E; Mularoni A; Reigadas E; Olmedo-Samperio M; Fernández-Ruiz M; Palacios-Baena ZR; Rodríguez-Baño J; De Simone P; Biancofiore G; Sabik EF; Paul M; Aguado JM; Boggi U; Muñoz P; Torres-Cisneros J; Farcomeni A; Falcone M;
    J Infect; 2024 Dec; 89(6):106306. PubMed ID: 39374859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effectiveness of abstinence-based and harm reduction-based interventions in reducing problematic substance use in adults who are experiencing homelessness in high income countries: A systematic review and meta-analysis: A systematic review.
    O'Leary C; Ralphs R; Stevenson J; Smith A; Harrison J; Kiss Z; Armitage H
    Campbell Syst Rev; 2024 Jun; 20(2):e1396. PubMed ID: 38645303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the Application of Topical Vancomycin Reduce Surgical Site Infections in Spine Surgery? A Meta-analysis of Randomized Controlled Trials.
    Daher M; Nassar JE; McDonald CL; Diebo BG; Daniels AH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2212-2219. PubMed ID: 38996386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collagenase injection versus limited fasciectomy surgery to treat Dupuytren's contracture in adult patients in the UK: DISC, a non-inferiority RCT and economic evaluation.
    Dias J; Tharmanathan P; Arundel C; Welch C; Wu Q; Leighton P; Armaou M; Corbacho B; Johnson N; James S; Cooke J; Bainbridge C; Craigen M; Warwick D; Brady S; Flett L; Jones J; Knowlson C; Watson M; Keding A; Hewitt C; Torgerson D
    Health Technol Assess; 2024 Dec; 28(78):1-262. PubMed ID: 39644138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.